icone plus 
	     
	    
	    
	    	
	
	
		
		
	
	     
	    
		
			
		 
		
			
		 
		
			
			
			
		 
		
			
				Contact  
				Abonnez-vous aux actualités 
			 
		 
		
	 
 
     
    
   
  
  
	 
	 
	 
	 
	 
 
  
	 
	
		
			
			
			
				
  
    
  
	
    
        
            
            
                
                
	                
	                 
	                    
	                    
	                        
	                            
								
									Reason for request 
									
										Inclusion
									
									
								 	
												
									                            
								
									
										
										
											
 
 
  
 
										
									
									
								
						 		
						 		
						 			 
									
										Clinical Benefit 
									 
									
										
											
											
												Insufficient 
												
													
														
															The actual benefit of CLIMASTON 0.5 mg/2.5 mg is insufficient for reimbursement by National Health Insurance in the Marketing Authorisation indication.
 
														
													 
												
											 
										
									
									
								
								
								
						 
						 		
						 		
								
						 		
								
	                         
	                     
                 
				
				
     
	 
				
		
				
		
	
 	 
				
		
                
                
                
				
	
                   
                
                
                
	
                
             
         
     
	
 
        
  
			
		
	 
	
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
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
1uz0e7LbG0upUB8B